{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:59:50Z","timestamp":1790229590698,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T00:00:00Z","timestamp":1712966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009337","name":"Saitama Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009337","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>This study aimed to investigate the factors affecting extraocular muscle enlargement in thyroid eye disease (TED).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Study design<\/jats:title>\n                <jats:p>Retrospective study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The thyroid-stimulating hormone (TSH) receptor antibody (TRAb), thyroid-stimulating antibody (TSAb), antithyroid peroxidase antibody (ATPO), and antithyroglobulin antibody (ATG) levels in patients diagnosed with TED who underwent orbital magnetic resonance imaging were assessed. The control group comprised the contralateral eye of patients who underwent orbital magnetic resonance imaging (MRI) for unilateral eyelid tumors or orbital disease. The thickness of the bilateral rectus muscles and superior oblique muscles was measured on orbital MRI. Muscle enlargement was classified as unilateral\/bilateral and symmetric\/asymmetric. The effects of age, sex, smoking history, TSH, thyroid hormone, and thyroid autoantibodies on the muscle thickness and number of enlarged muscles were assessed by use of simple and multiple regression analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The TED and control groups comprised 41 and 44 cases, respectively. The positivity rate of TSAb in patients with TED was 92.7% higher than that of the other autoantibodies. Muscle enlargement was observed in 29 of the 41 cases (70.7%). Older age and higher TSAb levels were identified as significant factors affecting the total muscle thickness and number of enlarged muscles. Bilateral muscle enlargement and asymmetrical muscle enlargement were observed in 17 (58.6%) and 23 (79.3%) of the 29 cases, respectively. The TSAb levels and age had no significant effect on the type of muscle enlargement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TSAb showed significant associations with extraocular muscle enlargement. Measurement of TSAb, rather than of TRAb, may be more useful for diagnosing extraocular muscle enlargement in patients with TED.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10384-024-01061-7","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T03:42:37Z","timestamp":1712979757000},"page":"250-258","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Correlation between extraocular muscle enlargement and thyroid autoantibodies in thyroid eye disease"],"prefix":"10.1007","volume":"68","author":[{"given":"Takahiro","family":"Koizumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Obata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,13]]},"reference":[{"key":"1061_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2169\/internalmedicine.53.1518","volume":"53","author":"Y Hiromatsu","year":"2014","unstructured":"Hiromatsu Y, Eguchi H, Tani J, Kasaoka M, Teshima Y. Graves\u2019 ophthalmopathy: epidemiology and natural history. Intern Med. 2014;53:353\u201360.","journal-title":"Intern Med"},{"key":"1061_CR2","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40618-018-0945-6","volume":"41","author":"S Seo","year":"2018","unstructured":"Seo S, S\u00e1nchez RM. Usefulness of TSH receptor antibodies as biomarkers for Graves\u2019 ophthalmopathy: a systematic review. J Endocrinol Invest. 2018;41:1457\u201368.","journal-title":"J Endocrinol Invest"},{"key":"1061_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/thy.2000.10.809","volume":"10","author":"JY Noh","year":"2000","unstructured":"Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid-stimulating antibody is related to Graves\u2019 ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves\u2019 disease. Thyroid. 2000;10:809\u201313.","journal-title":"Thyroid"},{"key":"1061_CR4","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.ophtha.2011.03.030","volume":"118","author":"KA Ponto","year":"2011","unstructured":"Ponto KA, Kanitz M, Olivo PD, Pitz S, Pfeiffer N, Kahaly GJ. Clinical relevance of thyroid-stimulating immunoglobulins in Graves\u2019 ophthalmopathy. Ophthalmology. 2011;118:2279\u201385.","journal-title":"Ophthalmology"},{"key":"1061_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3349\/ymj.2013.54.4.1033","volume":"54","author":"SY Jang","year":"2013","unstructured":"Jang SY, Shin DY, Lee EJ, Choi YJ, Lee SY, Yoon JS. Correlation between TSH receptor antibody assays and clinical manifestations of Graves\u2019 orbitopathy. Yonsei Med J. 2013;54:1033\u20139.","journal-title":"Yonsei Med J"},{"key":"1061_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3341\/kjo.2015.29.4.213","volume":"29","author":"YJ Woo","year":"2015","unstructured":"Woo YJ, Jang SY, Lim TH, Yoon JS. Clinical association of thyroid stimulating hormone receptor antibody levels with disease severity in the chronic inactive stage of Graves\u2019 orbitopathy. Korean J Ophthalmol. 2015;29:213\u20139.","journal-title":"Korean J Ophthalmol"},{"key":"1061_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1507\/endocrj.EJ15-0137","volume":"63","author":"K Mukasa","year":"2016","unstructured":"Mukasa K, Yoshimura Noh J, Kouzaki A, Ohye H, Kunii Y, Watanabe N, et al. TSH receptor antibody titers measured with a third-generation assay did not reflect the activity of Graves\u2019 ophthalmopathy in untreated Japanese Graves\u2019 disease patients. Endocr J. 2016;63:151\u20137.","journal-title":"Endocr J"},{"key":"1061_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1600-0420.2005.00617.x","volume":"84","author":"J Kvetny","year":"2006","unstructured":"Kvetny J, Puhakka KB, Rohl L. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis. Acta Ophthalmol Scand. 2006;84:419\u201323.","journal-title":"Acta Ophthalmol Scand"},{"key":"1061_CR9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1507\/endocrj.EJ19-0398","volume":"67","author":"Y Hiromatsu","year":"2020","unstructured":"Hiromatsu Y, Eguchi H, Matsuo Y, Kato T, Tani J, Watanabe S, et al. Role of a new bioassay for thyroid-stimulating antibodies (aequorin TSAb) in Graves\u2019 ophthalmopathy. Endocr J. 2020;67:347\u201352.","journal-title":"Endocr J"},{"key":"1061_CR10","doi-asserted-by":"publisher","first-page":"13781","DOI":"10.1038\/s41598-021-93275-9","volume":"11","author":"JH Choi","year":"2021","unstructured":"Choi JH, Noh H, Kim YD, Woo KI. Prognostic factors of restrictive myopathy in thyroid eye disease. Sci Rep. 2021;11:13781.","journal-title":"Sci Rep"},{"key":"1061_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2147\/OPTH.S61041","volume":"10","author":"SC Kavoussi","year":"2014","unstructured":"Kavoussi SC, Giacometti JN, Servat JJ, Levin F. The relationship between sex and symmetry in thyroid eye disease. Clin Ophthalmol. 2014;10:1295\u2013300.","journal-title":"Clin Ophthalmol"},{"key":"1061_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.611845","volume":"17","author":"G Panagiotou","year":"2020","unstructured":"Panagiotou G, Perros P. Asymmetric Graves\u2019 orbitopathy. Front Endocrinol (Lausanne). 2020;17: 611845.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1061_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s40618-020-01258-w","volume":"43","author":"P Perros","year":"2020","unstructured":"Perros P, \u017darkovi\u0107 MP, Panagiotou GC, Azzolini C, Ayvaz G, Baldeschi L, et al. Asymmetry indicates more severe and active disease in Graves\u2019 orbitopathy: results from a prospective cross-sectional multicenter study. J Endocrinol Invest. 2020;43:1717\u201322.","journal-title":"J Endocrinol Invest"},{"key":"1061_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4103\/0301-4738.83612","volume":"59","author":"MB Kashkouli","year":"2011","unstructured":"Kashkouli MB, Kaghazkanani R, Heidari I, Ketabi N, Jam S, Azamia S, et al. Bilateral versus unilateral thyroid eye disease. Indian J Opthalmol. 2011;59:363\u20136.","journal-title":"Indian J Opthalmol."},{"key":"1061_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00276-022-02915-w","volume":"44","author":"K Rana","year":"2022","unstructured":"Rana K, Juniat V, Rayan A, Patel S, Selva D. Normative measurements of the superior oblique and inferior oblique muscles by magnetic resonance imaging. Surg Radiol Anat. 2022;44:521\u20135.","journal-title":"Surg Radiol Anat"},{"key":"1061_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1061_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362:726\u201338.","journal-title":"N Engl J Med"},{"key":"1061_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41433-018-0279-9","volume":"33","author":"Y Huang","year":"2019","unstructured":"Huang Y, Fang S, Li D, Zhou H, Li B, Fan X. The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy. Eye (Lond). 2019;33:176\u201382.","journal-title":"Eye (Lond)"},{"key":"1061_CR19","doi-asserted-by":"publisher","first-page":"7453260","DOI":"10.1155\/2019\/7453260","volume":"2019","author":"D Lacheta","year":"2019","unstructured":"Lacheta D, Mi\u015bkiewicz P, G\u0142uszko A, Nowicka G, Struga M, Kantor I, et al. Immunological aspects of Graves\u2019 ophthalmopathy. Biomed Res Int. 2019;2019:7453260.","journal-title":"Biomed Res Int"},{"key":"1061_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.952954","volume":"13","author":"J Zheng","year":"2022","unstructured":"Zheng J, Duan H, You S, Liang B, Chen Y, Huang H. Research progress on the pathogenesis of Graves\u2019 ophthalmopathy: based on immunity, noncoding RNA and exosomes. Front Immunol. 2022;13: 952954.","journal-title":"Front Immunol"},{"key":"1061_CR21","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/S0161-6420(84)34152-5","volume":"91","author":"TJ Hufnagel","year":"1984","unstructured":"Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves\u2019 disease. Ophthalmology. 1984;91:1411\u20139.","journal-title":"Ophthalmology"},{"key":"1061_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1365-2249.1997.4491347.x","volume":"109","author":"A Pappa","year":"1997","unstructured":"Pappa A, Calder V, Ajjan R, Fells P, Ludgate M, Weetman AP, et al. Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol. 1997;109:362\u20139.","journal-title":"Clin Exp Immunol"},{"key":"1061_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2214\/ajr.179.4.1791005","volume":"179","author":"Z Szucs-Farkas","year":"2002","unstructured":"Szucs-Farkas Z, Toth J, Balazs E, Galuska L, Burman KD, Karanyi Z, et al. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves\u2019 ophthalmopathy: diameters, areas or volumes? AJR Am J Roentgenol. 2002;179:1005\u201310.","journal-title":"AJR Am J Roentgenol"},{"key":"1061_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10792-010-9368-x","volume":"30","author":"S El-Kaissi","year":"2010","unstructured":"El-Kaissi S, Bowden J, Henry MJ, Yeo M, Champion BL, Brotchie P, et al. Association between radioiodine therapy for Graves\u2019 hyperthyroidism and thyroid-associated ophthalmopathy. Int Ophthalmol. 2010;30:397\u2013405.","journal-title":"Int Ophthalmol"},{"key":"1061_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s004170050370","volume":"238","author":"S Tian","year":"2000","unstructured":"Tian S, Nishida Y, Isberg B, Lennerstrand G. MRI measurements of normal extraocular muscles and other orbital structures. Graefes Arch Clin Exp Ophthalmol. 2000;238:393\u2013404.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1061_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/OPTH.S105096","volume":"20","author":"T Higashiyama","year":"2016","unstructured":"Higashiyama T, Nishida Y, Ohji M. Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy. Clin Ophthalmol. 2016;20:721\u20139.","journal-title":"Clin Ophthalmol"},{"key":"1061_CR27","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s004170100352","volume":"239","author":"Y Nishida","year":"2001","unstructured":"Nishida Y, Tian S, Isberg B, Tallstedt L, Lennerstrand G. MRI measurements of orbital tissues in dysthyroid ophthalmopathy. Graefes Arch Clin Exp Ophthalmol. 2001;239:824\u201331.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1061_CR28","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1167\/iovs.09-3614","volume":"51","author":"S Shen","year":"2010","unstructured":"Shen S, Fong KS, Wong HB, Looi A, Chan LL, Rootman J, et al. Normative measurements of the Chinese extraocular musculature by high-field magnetic resonance imaging. Investig Ophthalmol Vis Sci. 2010;51:631\u20136.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1061_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/00004728-200005000-00025","volume":"24","author":"A \u00d6zgen","year":"2000","unstructured":"\u00d6zgen A, Ayding\u00f6z U. Normative measurements of orbital structures using MRI. J Comput Assist Tomogr. 2000;24:493\u20136.","journal-title":"J Comput Assist Tomogr"},{"key":"1061_CR30","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1007\/s10792-022-02407-1","volume":"42","author":"K Rana","year":"2022","unstructured":"Rana K, Juniat V, Rayan A, Patal S, Selva D. Normative measurements of orbital structures using magnetic resonance imaging. Int Ophthalmol. 2022;42:3869\u201375.","journal-title":"Int Ophthalmol"},{"key":"1061_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/archopht.120.3.380","volume":"120","author":"M Kazim","year":"2002","unstructured":"Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid-associated orbitopathy. Arch Ophthalmol. 2002;120:380\u20136.","journal-title":"Arch Ophthalmol"},{"key":"1061_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/01676830.2019.1594969","volume":"39","author":"Y Wang","year":"2020","unstructured":"Wang Y, Mettu P, Broadbent T, Radke P, Firl K, Shepherd JB 3rd, et al. Thyroid eye disease presenting with superior rectus\/levator complex enlargement. Orbit. 2020;39:5\u201312.","journal-title":"Orbit"},{"key":"1061_CR33","first-page":"2830","volume":"80","author":"MC Villadolid","year":"1995","unstructured":"Villadolid MC, Yokoyama N, Izumi M, Nishikawa T, Kimura H, Ashizawa K, et al. Untreated Graves\u2019 disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance. J Clin Endocrinol Metab. 1995;80:2830\u20133.","journal-title":"J Clin Endocrinol Metab"},{"key":"1061_CR34","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3892\/etm.2021.10781","volume":"22","author":"ML Macovei","year":"2021","unstructured":"Macovei ML, Azis \u0170, Gheorghe AG, Burcea M. A systematic review of euthyroid Graves\u2019 disease (review). Exp Ther Med. 2021;22:1346.","journal-title":"Exp Ther Med"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01061-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01061-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:05:47Z","timestamp":1715317547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01061-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,13]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1061"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01061-7","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,13]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. Koizumi, None; T. Tanaka, None; K. Umeda, None; D. Komiyama, None; H. Obata, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}